Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

Get updates on Compliance Week offerings, including new features, databases, research, and other resources, along with announcements of upcoming Webcasts, conferences, seminars, CPE/CLE opportunities and more.

Published every Thursday, Compliance Week Europe offers a condensed summary of risk, audit, and compliance news either originating in Europe, or of special interest to European compliance professionals. This newsletter will follow developments by the European Commission, as well as those of national governments across the region, or any U.S.-based news that might have consequence across the Atlantic. Frequency: weekly; Thursday a.m.

A fresh edition of Compliance Week delivered via e-mail and online every Tuesday morning, relentlessly focused on the disclosure, reporting and compliance requirements of our 25,000+ paying subscribers.

Published every Friday, Compliance Weekend was launched at the behest of subscribers, and offers a quick Plain English review of the week's key developments. We hope you enjoy this supplement to Compliance Week's Tuesday edition.


Status message

Start your free, no obligation 10-day trial to continue exploring with full access.

Mitigating FCPA Risks in Pharma, Med Device Sectors

Jaclyn Jaeger | March 17, 2015

Compliance officers in the pharmaceutical industry have a few new clues to consider from a top voice at the Securities and Exchange Commission about violations of the Foreign Corrupt Practices Act, and how to avoid them.

In remarks at a recent pharmaceutical industry conference, SEC Director of Enforcement Andrew Ceresney described FCPA enforcement in the pharma sector as a high priority. “Our FCPA focus obviously covers many industries,” Ceresney said. “But the pharma industry is one on which we have been particularly focused in recent years.”

Ceresney-andrew-0914FCPA risk is painfully high for pharma and medical device companies, because so much of their business overseas involves working with government-run healthcare systems. “Pharmaceutical representatives have regular contact with doctors, pharmacists, and... To get the full story, subscribe now.